Moderate to Severe Plaque Type Psoriasis research hub

A Phase 3b, Randomized, Double-blind, Parallel Group, Multicenter Study to Evaluate Further Therapeutic Strategies with Guselkumab in Patients with Moderate-to-Severe Plaque-Type Psoriasis

This study is testing a new way to treat moderate to severe psoriasis. We want to see if combining the existing medicine guselkumab with other treatments works better. Doctors will compare different treatment plans to find the most effective and safest options for people living with psoriasis.